top of page
Search
Gabriel Korn
Aug 7, 20242 min read
#Cystitis: Yesterday, Today and Tomorrow
Historically, #cystitis generally was a problem for women, who otherwise were well. They suffered in silence, drank water like fish, and,...
3 views0 comments
Scott Glickman
Jun 25, 20241 min read
A meeting with the UK health Security Agency on #antimicrobial resistance (AMR) development from cystitis treatments
Colleagues Some good news: I had a meeting with the #UKHSA this week to present my root cause analysis on #AMR. I was met by insightful...
6 views0 comments
Scott Glickman
Jun 6, 20241 min read
The new UK anti-AMR strategy plan
Colleagues I’ve been wading through the UK #governments second 5-year anti-AMR action plan, “Confronting #AntimicrobialResistance 2024-20...
1 view0 comments

Scott Glickman
Apr 24, 20241 min read
Cystitis and AMR. A critical analysis in <300 words,
UroPharma produced #intravesical drug-delivery technology to bring, under licence, better cystitis (lower #UTI) treatments. For decades,...
0 views0 comments
Scott Glickman
Apr 9, 20241 min read
Success, dependence and demise or innovation
When we find a solution to a problem, naturally we look to the same approach for the next similar challenge. #Antibiotics changed the...
4 views0 comments
Gabriel Korn
Feb 19, 20241 min read
"We know almost nothing about managing UTI"
“We know almost nothing about managing UTI.” This assertion went unchallenged at the British Society of #Antimicrobial Chemotherapy...
11 views0 comments
Gabriel Korn
Jan 26, 20241 min read
Responsible antibiotic stewardship
By Prof. Scott Glickman If a drug treatment for #cystitis is approved by a patient safety regulatory agency, without evidence that it can...
4 views0 comments
Gabriel Korn
Jan 23, 20242 min read
More on #Cystitis and #AMR
Homeostatic mechanisms optimise our cellular chemistry. #antibiotics treatments are developed specifically to work in our narrow-band...
7 views0 comments
bottom of page